Skip to main content
MapleLMS Implementation
Conferences and Meetings 904. Outcomes Research: Hemoglobinopathies: Poster I

904. Outcomes Research: Hemoglobinopathies: Poster I

Short name: 904. Outcomes Research: Hemoglobinopathies: Poster I
Course start date: 11/05/2025

Sections

General
0 activities

Caregiver and Provider Reports of Symptom Severity, Functionality, and Quality of Life Lack Congruence with Patient Reports in Pediatric Sickle Cell Disease
Delayed Physical Growth and Related Factors in Pediatric Patients with Transfusion-Dependent Thalassemia
High Concordance between Investigator-Verified Diagnosis and Manual Data Abstraction for Sickle Cell Diagnosis Type: An ASH Research Collaborative Data Hub Validation Study
Intersection of Pain-Related Healthcare Utilization with Neighborhood Factorsin Adults Living with Sickle Cell Disease
Opioid Overdose in Patients with Sickle Cell Disease, Outcomes Among Hospitalized Patients in the United States: A Nationwide Analysis
Pain-Specific Patient-Reported Outcomes Are Worse in Adults Compared to Children with Sickle Cell Disease
Pre-Transplant Liver Fibrosis Predicts Poor Overall Survival Following Hematopoietic Stem Cell Transplantation for Sickle Cell Disease
Prevalence of Pulmonary Hypertension in Patients Hospitalized with Sickle Cell Crisis
Thalassemia Scenario in Brazil: A Descriptive Study
Voxelotor Therapy Reduces Whole Blood Adhesion to VCAM-1 and P-Selectin, and Shows Modest Improvements in Self-Reported Pain in a Real-World Clinical Setting in a Multi-Center Retrospective Analysis